Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Golgi alpha-1,2-mannosidases IA, IB, and IC are members of the glycoside hydrolase family 47 (GH47) and localize predominantly to the Golgi apparatus in mammalian cells. They catalyze the hydrolysis of terminal alpha-1,2-linked mannose residues from Man8-9GlcNAc2 intermediates, yielding Man5GlcNAc2, a key step in the maturation of N-linked glycoproteins. This action is crucial for proper glycoprotein folding, trafficking, and quality control, and these enzymes contribute to both normal glycoprotein processing and endoplasmic reticulum-associated degradation (ERAD) by generating glycan signals that mark misfolded proteins for degradation. Dysregulation or inhibition of these enzymes can influence disease processes such as cancer and congenital disorders of glycosylation.
Competitive inhibition of the alpha-1,2-mannosidase active site by structural analogs of mannose or transition-state mimics, preventing processing of N-linked glycans and altering glycoprotein maturation
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Golgi alpha-1,2-mannosidase IA, IB, and IC (MAN1A1, MAN1A2, MAN1C1).